We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Sourcebio International Plc | LSE:SBI | London | Ordinary Share | GB00BKSB1674 | ORD GBP0.0015 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 115.00 | 105.00 | 150.00 | 0.00 | 00:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Dec 2021 to Dec 2024
TIDMSBI
RNS Number : 6375B
SourceBio International PLC
14 February 2022
14 February 2022
SourceBio International plc
(" SourceBio", the "Company" or the "Group")
Director/PDMR Shareholding
SourceBio International plc ("the Company") has been notified that on 14 February 2022, Harwood Capital LLP transferred 568,460 ordinary shares of 0.15 pence each in the Company ("Ordinary Shares") to Limited Partners of Harwood Private Equity IV L.P. ("HPE4") in order to satisfy distributions, in the normal course of business.
Christopher Mills, Non-Executive Director of the Company is Chief Executive of Harwood Capital LLP.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
Hot Features
Premium
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Harwood Capital LLP as investment
manager
---------------------------------- -----------------------------------------
2 Reason for the notification
-----------------------------------------------------------------------------
a) Position/status Christopher Mills is a non-executive
director of the issuer and Chief
Executive of the investment manager
---------------------------------- -----------------------------------------
b) Initial notification Initial Notification
/Amendment
---------------------------------- -----------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-----------------------------------------------------------------------------
a) Name SourceBio International Plc
---------------------------------- -----------------------------------------
b) LEI 213800KY4C9WU7WBW518
---------------------------------- -----------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-----------------------------------------------------------------------------
a) Description of the Ordinary shares of GBP0.0015 each
financial instrument,
type of instrument
Identification code GB00BKSB1674
b) Nature of the transaction Transfer of shares
---------------------------------- -----------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
Nil 568,460
----------
-------------------------------------
d) Aggregated information
N/A - single transaction
Volume
Price
e) Date of the transaction 14 February 2022
f) Place of the transaction Off market
---------------------------------- -----------------------------------------
TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
GB00BKSB1674
Issuer Name
SOURCEBIO INTERNATIONAL PLC
UK or Non-UK Issuer
UK
2. Reason for Notification
An acquisition or disposal of voting rights
3. Details of person subject to the notification obligation
Name
Harwood Capital Management (Gibraltar) Limited
City of registered office (if applicable)
Gibraltar
Country of registered office (if applicable)
Gibraltar
Name City of registered office Country of registered office
Harwood Capital LLP London United Kingdom
=========================== ==============================
4. Details of the shareholder
Name City of registered office Country of registered office
Oryx International Growth Fund Limited St Peter Port Guernsey
=========================== ==============================
North Atlantic Smaller Companies Investment Trust plc London United Kindom
=========================== ==============================
Harwood Capital LLP London United Kingdom
=========================== ==============================
5. Date on which the threshold was crossed or reached
14-Feb-2022
6. Date on which Issuer notified
14-Feb-2022
7. Total positions of person(s) subject to the notification obligation
% of voting rights % of voting rights Total of both in % Total number of
attached to shares through financial (8.A + 8.B) voting rights held
(total of 8.A) instruments (total in issuer
of 8.B 1 + 8.B 2)
Resulting situation
on the date on
which threshold
was crossed or
reached 22.680000 0.000000 22.680000 16824766
====================== ====================== ====================== ======================
Position of
previous
notification (if
applicable) 23.540000 0.000000 23.540000 17464284
====================== ====================== ====================== ======================
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached
8A. Voting rights attached to shares
Class/Type of shares Number of direct Number of indirect % of direct voting % of indirect voting
ISIN code(if possible) voting rights (DTR5.1) voting rights rights (DTR5.1) rights (DTR5.2.1)
(DTR5.2.1)
GB00BKSB1674 1074766 1.450000
====================== ====================== ====================== ======================
GB00BKSB1674 13250000 17.860000
====================== ====================== ====================== ======================
GB00BKSB1674 2500000 3.370000
====================== ====================== ====================== ======================
Sub Total 8.A 16824766 22.680000%
============================================== ==============================================
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
Type of financial Expiration date Exercise/conversion period Number of voting rights % of voting rights
instrument that may be acquired if
the instrument is
exercised/converted
Sub Total 8.B1
=========================================== ========================= ==================
8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))
Type of financial Expiration date Exercise/conversion Physical or cash Number of voting % of voting rights
instrument period settlement rights
Sub Total 8.B2
========================================================= =================== ==================
9. Information in relation to the person subject to the notification obligation
2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)
Ultimate controlling Name of controlled % of voting rights if % of voting rights Total of both if it
person undertaking it equals or is through financial equals or is higher
higher than the instruments if it than the notifiable
notifiable threshold equals or is higher threshold
than the notifiable
threshold
Christopher Harwood Oryx International
Bernard Mills Growth Fund Limited 3.370000
======================= ===================== ===================== ======================
North Atlantic
Smaller Companies
Christopher Harwood Investment Trust
Bernard Mills plc 17.860000
======================= ===================== ===================== ======================
Christopher Harwood
Bernard Mills Harwood Capital LLP 1.450000
======================= ===================== ===================== ======================
10. In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional Information
12. Date of Completion
14-Feb-2022
13. Place Of Completion
Off market
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHFLFLRFLISLIF
(END) Dow Jones Newswires
February 14, 2022 11:15 ET (16:15 GMT)
1 Year Sourcebio Chart |
1 Month Sourcebio Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
